Stockreport

Merck to further study Keytruda in prostate cancer after early success [Reuters (UK)]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Merck to further study Keytruda in prostate cancer after early success | Reuters 1 Min Read (Reuters) - Merck & Co Inc said on Thursday it was launching three late-stage [Read more]